A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.
We assessed the changes in cardiac condition in a patient with cardiac amyloidosis, by means of dual nuclei single photon emission computed tomographic (SPECT) images with technetium-99m-hydroxymethylene diphosphonate (99mTc-HMDP) and thallium-201 (201Tl). Dual SPECT showed a marked increase in myocardial 99mTc-HMDP accumulation along with deterioration of symptoms and signs, while 201Tl scintigraphy remained almost unchanged.
Kobayashi
T
T
Second Department of Internal Medicine, Ehime University School of Medicine, Japan.
Sekiya
M
M
Fujiwara
Y
Y
Sumimoto
T
T
Matsuoka
H
H
Hamada
M
M
Hiwada
K
K
D000368:Aged; D000686:Amyloidosis / Q000000981:diagnostic imaging*; D009202:Cardiomyopathies / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives*; D015899:Tomography, Emission-Computed, Single-Photon
C024226:technetium Tc 99m hydroxymethylene diphosphonate; D013669:Technetium Tc 99m Medronate